SCHEMBL2901773

SCHEMBL2901773

O=C(Nc1ccccc1C(=O)C(O)c1ccccc1)c1cccc(Cl)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
GPR139 Q6DWJ6 1/20 0.47
JAK2 O60674 1/20 0.47
LMNA P02545 4/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KDM4E B2RXH2 1/20 0.46
SMO Q99835 1/20 0.44
TSHR P16473 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3454583 0.84 TSHR (0.56) P2RX7HPGDGPR139JAK2LMNA
SCHEMBL15170179 0.81 BACE1 (0.59) HPGDLMNAMAPTMEN1KMT2A
SCHEMBL15590726 0.80 GPR139 (0.44) P2RX7GPR139JAK2LMNAMAPT
SCHEMBL2053138 0.78 LMNA (0.52) HPGDCYP2C19LMNAMEN1KMT2A
SCHEMBL44517 0.76 LMNA (0.57) HPGDCYP1A2CYP2C19GPR139LMNA
SCHEMBL15170369 0.76 KMT2A (0.55) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL5846337 0.76 F10 (0.62) HPGDMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL754132 0.76 CYP2C19 (0.58) HPGDCYP1A2CYP2C19LMNAMAPT
SCHEMBL8122020 0.76 NPC1 (0.67) P2RX7HPGDCYP1A2CYP2C19JAK2
SCHEMBL27896734 0.74 LMNA (0.50) P2RX7HPGDLMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION LTC4S, LTB4R2, LTB4R P2RX7 1064/4885HPGD 366/4885CYP1A2 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.